MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Abivax SA (ABVX)
Organization & Developments: Abivax
Parents
Abivax SA (ABVX)
Children
*A clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory disease
2022: French startup Abivax raises $49M to cross the PhIII finish line for ulcerative colitis drug
2025: Abivax stock soars on trial data for ulcerative colitis drug
2025: Abivax’s 580% surge hands biotech hedge funds a rare 2025 win
Jumps
Finance & Acquisitions: Abivax
Key People: Abivax